Dosage and Safety Regarding Potassium Iodide (KI) Usage?
In April of 1982 the Bureau of Radiological Health and Bureau of Drugs, Food and Drug Administration, Department of Health and Human Services released “FINAL RECOMMENDATIONS, Potassium Iodide As A Thyroid-Blocking Agent In A Radiation Emergency: Recommendations On Use”. These lengthy recommendations are summarized in the FDA’s “mandated patient product insert”. (See a complete copy below.) This insert is packed with every bottle of non-prescription Potassium Iodide (KI) tablets sold. However, the lengthy FDA recommendations contain many facts not mentioned in this required insert, including the following: “Based on the FDA adverse reaction reports and an estimated 48 x 106 [48 million] 300-mg doses of potassium iodide administered each year [in the United States], the NCRP [National Council on Radiation Protection and Measurements] estimated an adverse reaction rate of from 1 in a million to 1 in 10 million doses.” (It should be pointed out that this extremely low adverse reaction rate
